Technology

FASTer Way to Fat Loss Stands Firm with Proven, Growing Model Amid Industry SHifts

Published

2 years ago

October 1, 2024

FASTer Way to Fat Loss responds to the recent news that direct selling multi-level marketing models have restructured to accommodate a one-tier affiliate approach. FASTer Way was built on this approach nearly a decade ago and has sustained year over year revenue growth and empowered thousands of people to build their own successful fitness and nutrition franchise without the regulatory hassles.

CLEARWATER, Fla., Oct. 1, 2024 /PRNewswire-PRWeb/ — FASTer Way to Fat Loss, the premier digital fitness and nutrition program, today reaffirms its leadership position in the wellness industry with a proven, thriving business model that has demonstrated consistent growth since its launch. As competitors correct their strategies, FASTer Way continues to achieve significant milestones, boasting year-over-year revenue growth of nearly 25%, doubling annual revenue over the past five years, and expanding its international presence.

Since 2017, FASTer Way has been a stable and profitable opportunity for individuals seeking financial freedom in the digital fitness space. Coaches within the program regularly experience six-figure earnings, with some rising to multi-millionaire status through the program’s unique compensation model.

“We’ve proven the model works. While other companies regroup, we remain steadfast in our vision and growth,” said Amanda Tress, CEO and Founder of FASTer Way to Fat Loss. “Our professional certification and enhanced affiliate model have been fully optimized for several years, giving coaches immediate earning potential without the need for costly startup investments. We’re ready to embrace anyone who desires a fitness coaching franchise with a trusted program built on a solid foundation.”

As a pioneer of the enhanced affiliate marketing model and an expert in this space, Tress has consistently been an advocate for modernizing direct sales. Recently, she spoke at Direct Selling University, encouraging other companies to adopt an enhanced affiliate model. Tress’ insights on this innovative approach have helped distinguish FASTer Way as a sustainable solution for those looking to build their own businesses.

FASTer Way attributes its explosive growth to its dual revenue approach, combining a robust client sales program with a powerful affiliate and influencer marketing model that differentiates itself from traditional Multi-Level Marketing companies:

– Client Sales: Offers premium virtual fitness subscriptions with immediate access to meal plans, daily workouts, community support, and functional health services, all through the innovative FASTer Way app.

– Affiliate and Influencer Marketing: Provides an entrepreneurial opportunity for affiliates to build their business, earning generous commissions on client subscriptions and product sales without startup costs. FASTer Way’s network of over 5,000 certified coaches has seen commission payout growth of nearly 30% in 2024.

Key highlights of FASTer Way’s success include:

– 80% retention rates* and a healthy 25% annual user increase on the FASTer Way app.

– International expansion with a full launch of a Spanish-language program.

– Completion of a clinical trial validating the efficacy of the 6-Week New Client program in the app.

– Expansion into the consumables market, including a newly one-of-kind hydration product, along with other highly sought after supplements such as creatine and protein.

“Our vision for 2025 includes further investment in technology and emphasis on personalization, ensuring that our coaches and clients are equipped with cutting-edge tools like nutrition AI,” said Tress. “We are well on our way to becoming a billion-dollar brand revolutionizing the enhanced affiliate marketing model that others are chasing now.”

FASTer Way’s continued success demonstrates the strength of its business model, which empowers individuals, provides unmatched earning potential, and sets a new standard in the digital fitness space. Coaches and clients achieve their career and fitness goals due to this visionary model.

For more information about FASTer Way to Fat Loss or to explore coaching opportunities, visit fasterwaytofatloss.com.

Pull Quote

“Our professional certification and enhanced affiliate model have been fully optimized for several years, giving coaches immediate earning potential without the need for costly startup investments.” – Amanda Tress, FASTer Way to Fat Loss CEO and founder

Media Contact

RICHELLE HOENES, FASTer Way to Fat Loss, 1 9415440961, rhoenes@fasterwaytofatloss.com, fasterwaytofatloss.com

View original content to download multimedia:https://www.prweb.com/releases/faster-way-to-fat-loss-stands-firm-with-proven-growing-model-amid-industry-shifts-302264519.html

SOURCE FASTer Way to Fat Loss

Technology

Baidu to Report First Quarter 2026 Financial Results on May 18, 2026

Published

7 minutes ago

April 23, 2026

BEIJING, April 23, 2026 /PRNewswire/ — Baidu, Inc. (Nasdaq: BIDU; HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) (“Baidu” or the “Company”), a leading AI company with strong Internet foundation, today announced that it will report its financial results for the First Quarter 2026 ended March 31, 2026, before the U.S. market opens on May 18, 2026. Baidu’s management will hold an earnings conference call at 8:00 AM on May 18, 2026, U.S. Eastern Time (8:00 PM on May 18, 2026, Beijing Time).

Please register in advance of the conference call using the link provided below. It will automatically direct you to the registration page of “Baidu Inc. Q1 2026 Earnings Conference Call”. Please follow the steps to enter your registration details, then click “Register”. Upon registering, you will then be provided with the dial-in number, the passcode, and your unique access PIN. This information will also be emailed to you as a calendar invite.

For pre-registration, please click:
https://s1.c-conf.com/diamondpass/10054331-iu876y.html

In the 10 minutes prior to the call start time, you may use the conference access information (including dial-in number(s), the passcode and unique access PIN) provided in the calendar invite that you have received following your pre-registration.

Additionally, a live and archived webcast of this conference call will be available at https://ir.baidu.com.

A replay of the conference call may be accessed by phone at the following number until May 25, 2026:
US: 1 855 883 1031
Reply PIN: 10054331

About Baidu

Founded in 2000, Baidu’s mission is to make the complicated world simpler through technology. Baidu is a leading AI company with strong Internet foundation, trading on Nasdaq under “BIDU” and the HKEX under “9888.” One Baidu ADS represents eight Class A ordinary shares.

View original content:https://www.prnewswire.com/news-releases/baidu-to-report-first-quarter-2026-financial-results-on-may-18-2026-302751204.html

SOURCE Baidu, Inc.

Technology

Phase 1 of 139th Canton Fair Introduces New Dedicated Product Zones as Emerging Technologies Take Center Stage

Published

7 minutes ago

April 23, 2026

GUANGZHOU, China, April 23, 2026 /PRNewswire/ — The 139th China Import and Export Fair (Canton Fair) has further optimized its exhibition landscape with nine new dedicated product zones, reflecting ongoing structural shifts in global trade and the continued upgrading of China’s export portfolio.

Among the most closely watched additions in Phase 1 are the consumer and agricultural drone zones, both making their debut at the Canton Fair and offering a focused showcase of applications in the low‑altitude economy. The consumer drone zone showcases progress in flight control, AI‑based obstacle avoidance and energy efficiency across imaging, tourism, emergency response and patrol. The agricultural drone zone highlights precision farming, with spraying, seeding and field‑management demonstrations showing terrain‑following, intelligent route planning, and precise payload control.

On day one, a Shandong‑based drone manufacturer welcomed buyers from 30+ countries, with over 50 strong leads. One buyer, after seeing load and wind‑resistance demonstrations, immediately confirmed three sample units and even proposed becoming a regional distributor.

Display technology is another focal point of Phase 1, highlighting advances in color accuracy, energy efficiency, and overall visual performance. Developments in fine‑grained control, expanded color gamut, and reduced power consumption point to a clear trend toward immersive viewing experiences combined with sustainability gains.

The smart wearables zone underscores how intelligent devices are becoming key interfaces for human‑machine interaction. From real‑time language translation and adaptive noise cancellation to long‑term health monitoring and AI‑enabled eyewear, wearables are evolving from standalone products into integrated systems that support communication, well‑being, and productivity across daily and professional settings.

The service robots zone further illustrates how artificial intelligence is moving from conceptual exploration to large‑scale deployment. Advanced robots showcased across industrial, commercial, medical, and public‑service scenarios demonstrate growing autonomy, multi‑sensory perception, and closer human-robot collaboration.

By bringing emerging technologies into clearer focus through dedicated zones, the 139th Canton Fair is reinforcing its function as a platform where trade trends take shape, innovation meets application, and global buyers gain early insights into cutting-edge technologies.

For pre-registration, please click: https://buyer.cantonfair.org.cn/register/buyer/email?source_type=16

Photo – https://mma.prnewswire.com/media/2963958/1.jpg

View original content:https://www.prnewswire.co.uk/news-releases/phase-1-of-139th-canton-fair-introduces-new-dedicated-product-zones-as-emerging-technologies-take-center-stage-302751520.html

Technology

OZMOSI Announces Strategic Partnership with Planview to Advance AI-Driven Planning in Pharmaceutical R&D

Published

7 minutes ago

April 23, 2026

By combining structured clinical intelligence with AI-driven portfolio planning, the partnership gives pharmaceutical teams a faster, clearer way to make high-stakes R&D decisions

SPRING LAKE HEIGHTS, N.J., April 23, 2026 /PRNewswire/ — OZMOSI, a leading provider of structured pharmaceutical development intelligence, today announced a strategic partnership with Planview, the leading AI-powered end-to-end platform for Strategic Portfolio Management (SPM) and Digital Product Delivery (DPD).

By integrating OZMOSI’s machine-readable clinical datasets directly into Planview’s AI-driven portfolio planning platform, external scientific data is now connected to internal R&D planning in one system, helping pharmaceutical organizations better predict market shifts, prioritize R&D investments, and make faster, more confident decisions.

This integration brings external clinical reality into internal R&D decision-making, so teams can plan based on what’s actually happening, not just on what they hope will happen.

The two organizations combine deep expertise in complementary areas, united by a shared focus on improving the quality and usability of data for strategic decision-making. OZMOSI provides structured, machine-readable intelligence across clinical trials, drug development programs, regulatory activity, and scientific literature, built on a consistent taxonomy that standardizes how data is connected and understood. Planview’s platform enables organizations to model complex investment scenarios, align initiatives with corporate strategy, and optimize resource allocation.

Together, these capabilities give teams a clearer, more complete view of the R&D landscape, grounded in clean, standardized data and strengthened by AI-driven analysis.

“AI is only as powerful as the data that fuels it,” said Beau Bush, President and Founder of OZMOSI. “Pharmaceutical organizations have no shortage of data, but too often it’s fragmented, inconsistent, and difficult to operationalize. By bringing OZMOSI’s structured data foundation together with Planview’s AI-driven planning capabilities, we’re enabling teams to move beyond disconnected analysis and toward truly integrated, forward-looking decision-making.”

“Strategic planning in pharmaceutical R&D is becoming increasingly dependent on advanced analytics and AI,” said Louise Allen, Chief Product Officer at Planview. “Integrating OZMOSI’s clinical intelligence into Planview’s platform enables pharmaceutical leaders to make better decisions by combining trusted external data with AI-driven planning

OZMOSI’s dataset spans more than 800,000 clinical trials, over 35,000 drugs, and 4,000 diseases and conditions. It brings together insights from clinical trial registries, regulatory filings, scientific literature, company disclosures, and industry announcements into a unified, structured dataset.

When integrated into Planview’s platform, this intelligence enables pharmaceutical and biotech organizations to evaluate competitive landscapes, identify emerging clinical trends, and simulate portfolio outcomes with unprecedented precision.

Together, OZMOSI and Planview are redefining how pharmaceutical organizations approach R&D strategy, ensuring that investment decisions are guided by accurate, standardized, and AI-ready data. By combining internal portfolio visibility with a continuously updated external view of the market, the partnership helps leaders not only understand what they have, but what to do next.

About OZMOSI

Founded in 2013, OZMOSI specializes in transforming complex pharmaceutical R&D intelligence into structured, machine-readable data. The company provides the foundation needed for accurate competitive analysis, product forecasting, and portfolio strategy. Through its proprietary taxonomy and semantic layer, OZMOSI connects fragmented data across the pharmaceutical ecosystem, enabling faster, more confident decision-making for global pharma, biotech, and investment teams.

Based in Spring Lake Heights, New Jersey, OZMOSI is focused on making pharmaceutical intelligence clear, usable, and ready for the future of AI-driven strategy. Learn more at www.ozmosi.com.

About Planview

Planview is the leading end-to-end platform for Strategic Portfolio Management (SPM) and Digital Product Delivery (DPD), powered by advanced AI capabilities that give business and technology leaders the strategic foresight to prioritize investments and initiatives, make plans real within constraints, and pivot with certainty when things change. Our AI-driven connected platform of solutions underpins the business and digital transformations of more than 3,000 customers and 3.1 million users globally. Headquartered in Austin, Texas, Planview has over 1,500 employees worldwide. Learn more at www.planview.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ozmosi-announces-strategic-partnership-with-planview-to-advance-ai-driven-planning-in-pharmaceutical-rd-302750944.html

SOURCE Ozmosi Company